Five steps to better protect providers, medtech companies, their networks, data and patients from a cyberattack.
Thus far, the company has received 51 reports of serious injury and three reports of patient death over five years.
A global pandemic is still upon us, but that certainly does not mean that healthcare technology innovation is standing still. To help the medical device industry look to the future and prepare, experts from regulation and academia alike are bringing attention to the acceleration and pitfalls of innovation.
Healthcare cannot remain reactive to dealing with cybersecurity risks. We must take a new, proactive approach to protecting our users, and our systems must prioritize reducing the extent of reliance on users against unknown threats.
As more healthcare activities take place from home, passive continuous monitoring solutions and new technology such as artificial intelligence will be critical to communications between providers and patients. In addition, new solutions that offer overnight monitoring will play a crucial role in helping to fill the gaps, particularly in assessing patient deterioration or changes in health conditions. The pandemic has forever changed the trajectory of healthcare and specifically virtual care.
Increasing demand for custom surgical implants and growing investment in R&D will help the sector experience significant growth over the next five years.
Opportunities for intelligent computer systems span widely, including extensive use in medical science. Artificial intelligence enhances cognition analysis of complex health issues and improves the diagnoses. However, there are still some challenges in terms of data quality, regulations, market penetration and adaptation.
Clinical Trials Labeling and Regulated Content Management Added to Cloud-Based Platform
“The deal will help Stryker significantly accelerate [its] digital aspirations to improve the lives of caregivers and patients,” according to company Chair and CEO Kevin Lobo.
The center is also hoping to move back into more normal review timelines next year.